Acquisition adds oral solid dose development and small

收购增加了口服固体制剂开发和小

‑

‑

scale commercial manufacturing, expanding Codis' integrated spray dry offering in Europe

扩大商业化生产规模，拓展Codis在欧洲的一体化喷雾干燥服务

Nottingham team brings more than two decades of formulation and clinical supply expertise into the Codis organization

诺丁汉团队将二十多年的制剂和临床供应专业知识带入Codis组织

Combined with Codis' commercial

结合 Codis 的商业

‑

-

scale PSD

缩放功率谱密度

‑

-

4 investment in Haverhill, UK, the acquisition establishes the region's most comprehensive spray dry pathway from development to commercial intermediates and final dose forms

4 对英国哈弗希尔的投资，此次收购建立了该地区从研发到商业中间体及最终剂型的最全面的喷雾干燥工艺路径

HAVERHILL, England

英格兰哈弗希尔

,

，

Aug. 3, 2026

2026年8月3日

/PRNewswire/ -- Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering solutions, today announced the successful closing of its acquisition of Catalent's Nottingham, UK facility.

/美通社/ -- 专注于喷雾干燥、无定形固体分散体（ASD）和先进颗粒工程解决方案的全球合同研发与生产组织（CDMO）Codis 今日宣布，成功完成对卡特伦特英国诺丁汉工厂的收购。

Continue Reading

继续阅读

Global specialized CDMO Codis has acquired Catalent’s Nottingham, UK facility

全球专业CDMO公司Codis已收购Catalent位于英国诺丁汉的工厂

With the transaction now complete, Codis has created Europe's most compelling end‑to‑end spray dry capability, combining development‑scale spray drying, oral solid dose (OSD) formulation, analytical services, clinical supply, and small‑scale commercial manufacturing in Nottingham with the company's expanding commercial spray drying operations in Haverhill..

随着此次交易完成，Codis 打造了欧洲最具竞争力的端到端喷雾干燥能力，将位于诺丁汉的开发规模喷雾干燥、口服固体制剂（OSD）配方开发、分析服务、临床供应和小规模商业化生产，与公司在哈弗希尔不断扩展的商业化喷雾干燥运营相结合。

'

'

This is an exciting milestone for Codis

这是 Codis 的一个激动人心的里程碑

,' said Nicolas Fortin, CEO of Codis. '

Codis 首席执行官尼古拉·福尔坦表示：“

We are delighted to welcome the Nottingham team into the Codis family. Their scientific strength, development experience, and long track record of delivering high

我们很高兴欢迎诺丁汉团队加入 Codis 大家庭。他们拥有雄厚的科研实力、丰富的开发经验，以及长期交付高

‑

-

quality spray

优质喷雾

‑

‑

dried and oral solid dose solutions make them an exceptional addition to our organization. Together, Nottingham and Haverhill create a uniquely integrated pathway that allows customers to move from development to commercial manufacturing with greater speed, confidence, and continuity.

干燥和口服固体制剂解决方案使它们成为我们组织的卓越补充。诺丁汉和哈弗希尔共同创建了一条独特的集成路径，使客户能够以更快的速度、更高的信心和更强的连续性从开发阶段过渡到商业化生产。

'

'

Matthew Streeter, General Manager of the newly acquired site in Nottingham, who has been appointed to the Codis executive team, added, '

新收购的诺丁汉站点总经理马修·斯特里特（Matthew Streeter）已被任命为Codis执行团队成员，他补充道：“

My team and I are excited to join Codis and look forward to playing a big part in building an expanded, strategically important service at the company.

我和我的团队很兴奋加入 Codis，并期待在公司构建一个扩展的、具有战略重要性的服务中发挥重要作用。

'

'

The acquisition strategically complements Codis' large‑scale commercial spray drying facility in Haverhill, which is undergoing significant expansion with a new GEA Pharma‑SD® PSD‑4 commercial spray dryer scheduled for validation in 2027. The combined capabilities will enhance Codis' portfolio of bioavailability enhancement solutions and provide customers with a seamless route from early development through clinical supply and commercial intermediates to final oral dose forms..

此次收购在战略上补充了Codis位于哈夫希尔的大型商业化喷雾干燥设施，该设施正在大幅扩建，新增的一台GEA Pharma‑SD® PSD‑4商业化喷雾干燥机计划于2027年完成验证。整合后的能力将增强Codis在生物利用度提升解决方案方面的产品组合，为客户提供从早期开发、临床供应和商业化中间体到最终口服剂型的一体化无缝路径。

'

'

This combination gives the market something truly differentiated

这种组合为市场带来了真正具有差异化的产品

,' said Steve Facer, SVP Sales & Marketing at Codis. '

”Codis销售与营销高级副总裁Steve Facer表示，“

Codis now offers the most compelling spray dry offering in Europe with development expertise, integrated analytical support, clinical and small

Codis 现在提供欧洲最具竞争力的喷雾干燥服务，拥有开发专业知识、集成分析支持、临床和小规模

‑

‑

scale commercial manufacturing, and commercial

规模化商业制造，以及商业

‑

‑

scale spray drying all within one organization and one quality system. For customers working with poorly soluble molecules, this is the fastest and lowest

喷雾干燥的放大生产均在同一组织体系和同一质量体系内完成。对于处理难溶性分子的客户而言，这是最快且成本最低的方案

‑

‑

risk path to unlocking a molecule's full potential.

释放分子全部潜力的风险路径。

'

'

About Codis

关于 Codis

Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. With more than 400,000 sq ft of cGMP facilities in St. Louis, Missouri, Seymour, Indiana, and Nottingham and Haverhill, UK, Codis combines decades of regulatory expertise, development and manufacturing strength under one brand.

Codis 是一家全球性的合同研发生产组织（CDMO），专注于为制药、消费者健康、营养保健品和非处方药（OTC）领域提供商业化喷雾干燥、无定形固体分散体、粒子工程和成品制剂生产服务。Codis 在密苏里州圣路易斯、印第安纳州西摩以及英国的诺丁汉和哈弗希尔拥有超过 40 万平方英尺的 cGMP 设施，将数十年的监管专业知识、开发和制造实力融合于一个品牌之下。

Learn more at .

了解更多，请访问。

www.codis.com

www.codis.com

.

。

Media Contacts

媒体联系人

Gillian Lott                                                         Miles Fisher-Pollard

吉莉安·洛特 迈尔斯·费舍尔-波拉德

Codis                                                                 Orientation Marketing

Codis 定向营销

[email protected]

[email protected]

[email protected]

[email protected]

SOURCE Codis

来源 Codis

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示